Inovio Pharmaceuticals (INO) Financials

Inovio Pharmaceuticals Inc (INO) is a biotechnology company that develops and commercializes DNA-based immunotherapies and vaccines. The company focuses on the development of therapies for cancer, infectious diseases, and autoimmune disorders. INO's income statement provides a snapshot of the company's financial performance over a specific period. It shows the revenues earned, expenses incurred, and the resulting net income. Inovio Pharmaceuticals Inc reported a total revenue of $66.9 million for the year ending December 31, 2020, reflecting a 2% increase compared to the previous year. The company's gross profit was $41.6 million, and net income from stockholders stood at $-169.9 million.

The company's balance sheet provides a snapshot of its financial position at a specific point in time. Inovio Pharmaceuticals Inc had total assets of $646.4 million, total liabilities of $157.3 million, and stockholders' equity of $489.1 million as of December 31, 2020. Cash equivalents were reported at $82.4 million, and the company had no net debt.

Inovio Pharmaceuticals Inc's cash flow statement provides information about the cash generated and used by the company during a specific period. The operating cash flow, which measures the cash generated from the company's core operations, was $-89.6 million for the year ending December 31, 2020. The company had a financing cash flow of $134.2 million and an investing cash flow of $-66.3 million. The free cash flow, which represents the cash flow available for distribution to investors, was $-92.2 million.

In summary, Inovio Pharmaceuticals Inc's financials indicate a moderate increase in total revenue and a significant net loss for the year ending December 31, 2020. Although the company had a substantial amount of cash equivalents and no net debt, its operating cash flow was negative, and free cash flow remained negative as well. Investors and stakeholders should carefully consider the financial performance and position of the company before making any investment decisions.